The Artificial Intelligence in Genomics Market is expected to reach $6.22 billion by 2029, at a CAGR of 42.8% from 2022 to 2029.

Exploring Genomics and Its Importance Genomics is a field dedicated to studying an organism's complete set of genes. By analyzing, sequencing, and mapping genomes, scientists can gain deep insights into genetic structures and variations. The incorporation of AI in genomics has significantly boosted areas such as variant calling, genome annotation, variant classification, and genetic diagnosis. These advancements are spurring investments from various companies that aim to leverage genomics in drug discovery, diagnostics, and precision medicine. As technology progresses, it is becoming easier, quicker, and more affordable to map the human genome.

Download Sample Copy Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5345

Expanding the Scope of Genomic Research The applications of genomics stretch beyond medicine and into fields like biotechnology, agriculture, and social sciences. The growing reliance on AI in genomics has been fueled by the sheer volume of data generated. A report from the National Human Genome Research Institute in 2021 predicts that genomic research could generate 2 to 40 exabytes of data over the next decade. As DNA sequencing technology evolves, the complexity of this data increases, necessitating the use of AI to process, analyze, and interpret it.

AI's Role in Clinical Genomic Applications AI’s role in genomics extends beyond data management; it also enhances the interpretability of genomic data, helping transform it into actionable clinical insights. AI has the ability to develop targeted therapies that cater to different groups of patients based on their genetic profiles. This precision not only enhances treatment outcomes but also accelerates the development of personalized medicine solutions.

Notable AI-Driven Genomics Investments In recent years, significant investments have been made to accelerate the integration of AI into genomics. In March 2022, Illumina Accelerator funded several genomics startups working on breakthrough therapeutics and diagnostics solutions. NonExomics, an AI-driven company, is working on mapping novel drug targets from lesser-known areas of the genome. DNAnexus, another cloud-based platform, secured $200 million in funding to enhance its genomics platform, which leverages AI and machine learning. SeqOne Genomics, a biotech company based in France, raised $23.66 million to develop personalized genomic solutions, while Deep Genomics received $180 million to advance its AI-driven therapeutics platform.

Trending Blog : https://meticulousblog.org/the-growing-synergy-between-ai-and-genomics-revolutionizing-medicine-and-beyond

Conclusion The integration of AI into genomics research is reshaping the future of healthcare by unlocking new possibilities in drug discovery, diagnostics, and precision medicine. With investments pouring in and technological innovations continuously emerging, the AI genomics market is expected to grow at a compound annual growth rate of 42.8%, reaching $6.22 billion by 2029.

Key Players

The key players operating in the global AI in genomics market are Microsoft Corporation (U.S.), NVIDIA Corporation (U.S.), Deep Genomics Incorporated (Canada), Fabric Genomics, Inc. (U.S.), Data4Cure, Inc. (U.S.), Predictive Oncology Inc. (U.S.), Emedgene Technologies LTD (U.S.), Congenica Ltd. (U.K.), Tempus Labs, Inc. (U.S.), SOPHiA GENETICS SA (Switzerland), Illumina Inc. (U.S.), and BenevolentAI Limited. (U.K.).

Quick Buy : https://www.meticulousresearch.com/Checkout/40485578


About Meticulous Research®

Meticulous Research® is a leading provider of comprehensive market intelligence, offering actionable insights and analysis across various industries. Our reports empower businesses to make informed decisions, drive growth, and remain competitive in a rapidly evolving marketplace.

Contact:

Meticulous Market Research Pvt. Ltd.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- [email protected]
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research